Dexamethasone effects on the expression and content of glycosylated components of mouse brain tissue

Introduction. Glucocorticoids are actively used in the treatment of various diseases, however their long-term use leads to numerous negative side-effects, the molecular mechanisms of which remain poorly understood.Aim. Study of the short-term (1–10 days) effects of various doses of dexamethasone (Dex) (0,1–10 mg/kg) on the expression of the glucocorticoid receptor (GR, Nr3c1), core proteins of main proteoglycans and heparan sulfate metabolism-involved genes, as well as the content of carbohydrate macromolecules of glycosaminoglycans in the brain tissue of experimental animals.Materials and methods. In the study, C57Bl/6 mice were used. The expression of GR, proteoglycan core proteins and heparan sulfate metabolism-involved genes was determined by real-time polymerase chain reaction with reverse transcription. The content and localization of GR protein molecule were studied by Western blot and immunohistochemical analysis, and the glycosaminoglycan content was determined by dot-blot analysis and Alcian Blue staining.Results. It was shown that a single Dex administration leads to fast (1–3 days) short-term activation of GR expression (+1.5 times, p <0.05), proteoglycan’s genes (syndecan-3, Sdc3; perlecan, Hspg2; phosphacan, Ptprz1; neurocan, Ncan; +2–3-fold; p <0.05) and heparan sulfate-metabolism-involved genes (Ndst1, Glce, Hs2st1, Hs6st1, Sulf1 / 2; +1.5–2-fold; p <0.05) in the mouse brain, with a return to control values by 7–10 days after Dex administration. At the same time, the effect of Dex on carbohydrate macromolecules of glycosaminoglycans was more delayed and stable, increasing the content of low-sulfated glycosaminoglycans in the brain tissue in a dose-dependent manner starting from day 1 after Dex administration. Highly-sulfated glycosaminoglycans showed more delayed response to Dex administration, and an increase in their content was observed only at higher doses (2.5 and 10 mg/kg) and only on 7–10 days after its administration, apparently, mainly due to an increase in heparan sulfate content.Conclusion. In general, the effect of a single injection of Dex on the transcriptional activity of GR, proteoglycan core proteins and heparan sulfate metabolism-involved genes were short-termed, and the genes expression quickly returned to the normal levels. However, even a single use of Dex significantly increased the content of total as well as highly sulfated glycosaminoglycans in the mouse brain tissue, which can lead to the changes in the composition and structure of the brain tissue, as well as its functional characteristics.

[1]  E. Grigorieva,et al.  Glucocorticoid Effects on Proteoglycans and Glycosaminoglycans , 2022, International journal of molecular sciences.

[2]  C. Mazzanti,et al.  Sedoheptulose Kinase SHPK Expression in Glioblastoma: Emerging Role of the Nonoxidative Pentose Phosphate Pathway in Tumor Proliferation , 2022, International journal of molecular sciences.

[3]  O. Shevelev,et al.  Chemotherapy-Induced Degradation of Glycosylated Components of the Brain Extracellular Matrix Promotes Glioblastoma Relapse Development in an Animal Model , 2021, Frontiers in Oncology.

[4]  Xiaozhen Zhang,et al.  Activation of Glucocorticoid Receptor Inhibits the Stem-Like Properties of Bladder Cancer via Inactivating the β-Catenin Pathway , 2020, Frontiers in Oncology.

[5]  C. Libert,et al.  A General Introduction to Glucocorticoid Biology , 2019, Front. Immunol..

[6]  Jian Song,et al.  Chronic stress impairs the aquaporin-4-mediated glymphatic transport through glucocorticoid signaling , 2019, Psychopharmacology.

[7]  A. V. Suhovskih,et al.  Conventional Anti-glioblastoma Chemotherapy Affects Proteoglycan Composition of Brain Extracellular Matrix in Rat Experimental Model in vivo , 2018, Front. Pharmacol..

[8]  A. L. Krivoshapkin,et al.  Heparan sulfate accumulation and perlecan/HSPG2 up-regulation in tumour tissue predict low relapse-free survival for patients with glioblastoma , 2018, Histochemistry and Cell Biology.

[9]  Charles Nicholson,et al.  Brain Extracellular Space: The Final Frontier of Neuroscience. , 2017, Biophysical journal.

[10]  B. McEwen,et al.  Genomic and epigenomic mechanisms of glucocorticoids in the brain , 2017, Nature Reviews Endocrinology.

[11]  Yuchan Wang,et al.  Chronic dexamethasone treatment results in hippocampal neurons injury due to activate NLRP1 inflammasome in vitro , 2017, International immunopharmacology.

[12]  M. Piechota,et al.  Transcriptional signatures of steroid hormones in the striatal neurons and astrocytes , 2017, BMC Neuroscience.

[13]  K. Yamamoto,et al.  Glucocorticoid receptor control of transcription: precision and plasticity via allostery , 2017, Nature Reviews Molecular Cell Biology.

[14]  M. Shakibaei,et al.  Membrane-bound glucocorticoid receptors on distinct nociceptive neurons as potential targets for pain control through rapid non-genomic effects , 2016, Neuropharmacology.

[15]  Weizu Li,et al.  Chronic glucocorticoids exposure enhances neurodegeneration in the frontal cortex and hippocampus via NLRP-1 inflammasome activation in male mice , 2016, Brain, Behavior, and Immunity.

[16]  T. Rachner,et al.  Targeting syndecan-1 in breast cancer inhibits osteoclast functions through up-regulation of osteoprotegerin , 2013, Journal of bone oncology.

[17]  N. Mitrović,et al.  Low‐Dose Dexamethasone Treatment Promotes the Pro‐Survival Signalling Pathway in the Adult Rat Prefrontal Cortex , 2013, Journal of neuroendocrinology.

[18]  Conor Liston,et al.  Glucocorticoids are critical regulators of dendritic spine development and plasticity in vivo , 2011, Proceedings of the National Academy of Sciences.

[19]  Yi-Hsuan Lee,et al.  Methylprednisolone inhibits the expression of glial fibrillary acidic protein and chondroitin sulfate proteoglycans in reactivated astrocytes , 2008, Glia.

[20]  Wei-ping Li,et al.  Memory and learning impairment induced by dexamethasone in senescent but not young mice. , 2007, European journal of pharmacology.

[21]  Ravi V. Bellamkonda,et al.  Dexamethasone-coated neural probes elicit attenuated inflammatory response and neuronal loss compared to uncoated neural probes , 2007, Brain Research.

[22]  R. Tuan,et al.  Glucocorticoids Promote Chondrogenic Differentiation of Adult Human Mesenchymal Stem Cells by Enhancing Expression of Cartilage Extracellular Matrix Genes , 2006, Stem cells.

[23]  M. Joëls,et al.  Effect of brief corticosterone administration on SGK1 and RGS4 mRNA expression in rat hippocampus , 2006, Stress.

[24]  D. Friend,et al.  Glucocorticoids inhibit the cytokine-induced proliferation of mast cells, the high affinity IgE receptor-mediated expression of TNF-alpha, and the IL-10-induced expression of chymases. , 1997, Journal of immunology.

[25]  D. Beier,et al.  Structure and chromosomal localization of the mouse neurocan gene. , 1995, Genomics.

[26]  S. Sugiyama,et al.  Mouse aggrecan, a large cartilage proteoglycan: protein sequence, gene structure and promoter sequence. , 1995, The Biochemical journal.

[27]  J. Levine,et al.  Type II glucocorticoid receptors are expressed in oligodendrocytes and astrocytes , 1990, Journal of neuroscience research.

[28]  H. Akil,et al.  Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat. , 1989, Molecular endocrinology.